Open AccessExploratory Trial of Intranasal Administration of Glucagon-Like Peptide-1 in Japanese Patients With Type 2 Diabetes
Author(s) -
Hiroaki Ueno,
Masanari Mizuta,
Tomomi Shiiya,
Wakaba Tsuchimochi,
K. Noma,
Noboru Nakashima,
Mitsuteru Fujihara,
Masamitsu Nakazato
Publication year - 2014
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc13-0690
Subject(s) - medicine , nasal administration , placebo , type 2 diabetes , glucagon , adverse effect , diabetes mellitus , insulin , endocrinology , pharmacology , gastroenterology , pathology , alternative medicine
This study aimed to assess the efficacy and safety of our newly developed nasal glucagon-like peptide-1 (GLP-1) compound and injector.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom